CLINICAL_TRIALS
trial_result
· 2011-07-07
Clinical Trial Update: Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 2]
Summary
Phase 2 gene therapy trial for stage III or stage IV melanoma has completed; sponsor is Vical.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Vical | Conditions: Stage IV Melanoma, Stage III Melanoma | Phase 2 | Status: COMPLETED